(Q36243043)

13 August 2017

1 reference

title

Does the panic attack activate the hypothalamic-pituitary-adrenal axis? (English)

1 reference

Frederico Guilherme Graeff

13 August 2017

1 reference

Francisco Silveira Guimarães

1

object named as

Frederico G Graeff

0 references

4

object named as

Francisco S Guimarães

1 reference

13 August 2017

Frederico G Graeff

1

1 reference

13 August 2017

Cybele Garcia-Leal

2

1 reference

13 August 2017

Cristina M Del-Ben

3

1 reference

13 August 2017

publication date

24 August 2005

1 reference

Anais da Academia Brasileira de Ciências

13 August 2017

published in

1 reference

13 August 2017

volume

77

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

477-491

1 reference

Cholecystokinin-4 and panic.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Pentagastrin infusions in patients with panic disorder II. Neuroendocrinology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Anxiogenic properties of yohimbine. I. Behavioral, physiological and biochemical measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Neurobiology of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Endocrine and physiological changes during "spontaneous" panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Increased anxiogenic effects of caffeine in panic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Plasma cortisol concentrations preceding lactate-induced panic. Psychological, biochemical, and physiological correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Anxiety and salivary cortisol in symptomatic and nonsymptomatic panic patients and healthy volunteers performing simulated public speaking

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Response to hyperventilation in a group of patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Serotonin, the periaqueductal gray and panic

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Pharmacology of human experimental anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Effect of chlorimipramine and maprotiline on experimental anxiety in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Behavioral, sympathetic and adrenocortical responses to yohimbine in panic disorder patients and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Cortisol and sodium lactate-induced panic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Atrial natriuretic hormone in lactate-induced panic attacks: mode of release and endocrine and pathophysiological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Effects of propranolol on symptom and endocrine responses to pentagastrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Pituitary adrenocortical unresponsiveness in lactate-induced panic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Lactate provocation of panic attacks. II. Biochemical and physiological findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Elevated serum lactate associated with panic attacks induced by hyperventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

A historical view of the stress field

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Simulated public speaking as a model of clinical anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

d-Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Lactate Metabolism in Anxiety Neurosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

21 January 2018

Modeling panic attacks

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

L-5-hydroxytryptophan induced increase in salivary cortisol in panic disorder patients and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

A Syndrome produced by Diverse Nocuous Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Differential responses to anxiogenic challenge studies in patients with major depressive disorder and panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Fenfluramine provocation of anxiety in patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Forebrain pathways mediating stress-induced hormone secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Panic symptoms after inhalation of carbon dioxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

The cholecystokinin-B receptor antagonist CI-988 failed to affect CCK-4 induced symptoms in panic disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Behavioral, neuroendocrine and biochemical effects of different doses of 5-HTP in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Serotonin function in panic disorder: effect of 1-5-hydroxytryptophan in patients and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Situational panic attacks. Behavioral, physiologic, and biochemical characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Salivary Cortisol in Panic Attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0001-37652005000300009

10.1590/S0001-37652005000300009

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference